Single-dose psilocybin alters resting state functional networks in patients with body dysmorphic disorder
Psychedelics September 24, 2024 Xi Zhu, Chen Zhang, David J Hellerstein et al. 6 citations
Body dysmorphic disorder (BDD) is a severe psychiatric condition characterized by preoccupation with perceived flaws in one's appearance, which the individual views as defective or ugly. Psilocybin, a serotonin 2A receptor agonist with psychedelic properties, has emerged as a potential therapeutic agent for depression and other psychiatric disorders. This study aimed to identify subacute neural...
DOI: 10.61373/pp024r.0028 (opens in new tab)
Full text (opens in new tab)
Psilocybin
Default mode network
Body dysmorphic disorder
Resting State FMRI
+3